Health and Healthcare

Amgen : AMGN

All Amgen Articles

699 Articles

Chris Lange | Aug 26, 2020 at 10:13 AM EDT

Major Biotechs Scare Off Short Sellers

The August 14 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 24, 2020 at 6:25 PM EDT

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

The Dow Jones industrial average changes look a bit strange, and the real effort behind those changes may simply be…

Chris Lange | Aug 12, 2020 at 8:25 AM EDT

Short Sellers Shy Away From Big Biotech

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Jul 29, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate Technology,…

Chris Lange | Jul 27, 2020 at 9:41 AM EDT

Big Biotechs Scare Off Short Sellers

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Chris Lange | Jul 24, 2020 at 10:51 AM EDT

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm…

Lee Jackson | Jul 22, 2020 at 7:28 AM EDT

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

These four top Jefferies growth stock picks all offer investors strength in their specific industries and the ability to generate…

Jon C. Ogg | Jul 20, 2020 at 12:32 PM EDT

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Many investors feel like the key stocks in the market have simply gotten away from them, but those fears are…

Jon C. Ogg | Jul 20, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with…

Chris Lange | Jul 13, 2020 at 9:43 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Biotechs

The June 30 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Jun 25, 2020 at 9:46 AM EDT

Short Sellers Run for Cover From Major Biotechs

The June 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jun 10, 2020 at 10:01 AM EDT

Major Biotechs Have Short Sellers on the Run

The May 29 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | May 28, 2020 at 9:37 AM EDT

Major Biotechs See More Targeted Short Sellers

The May 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | May 12, 2020 at 9:36 AM EDT

Short Sellers Raise the Stakes in Major Biotechs

The April 30 short interest data has been compared with the previous report, and short interest in most of these…

1 … 8 9 10 11 12 … 47

Amgen : AMGN

All Amgen Articles

Major Biotechs Scare Off Short Sellers

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

Short Sellers Shy Away From Big Biotech

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Big Biotechs Scare Off Short Sellers

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Short Sellers Can’t Make Up Their Minds on Big Biotechs

Short Sellers Run for Cover From Major Biotechs

Major Biotechs Have Short Sellers on the Run

Major Biotechs See More Targeted Short Sellers

Short Sellers Raise the Stakes in Major Biotechs

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Amgen : AMGN

All Amgen Articles

Major Biotechs Scare Off Short Sellers

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

Short Sellers Shy Away From Big Biotech

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Big Biotechs Scare Off Short Sellers

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Short Sellers Can’t Make Up Their Minds on Big Biotechs

Short Sellers Run for Cover From Major Biotechs

Major Biotechs Have Short Sellers on the Run

Major Biotechs See More Targeted Short Sellers

Short Sellers Raise the Stakes in Major Biotechs

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do